• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Oxygenta Pharmaceutical Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 19443.0
  • ISIN : INE102E01018
105.00 -3 (-2.96%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    105.00

  • Today’s High

    108.70

  • Open

    108.70

  • Perv Close

    108.20

  • 52W Low

    30.40

  • 52W High

    133.50

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    388.33

  • Div & Yield %

    0.00

  • Book Value(₹)

    -6.93

  • Debt-Equity Ratio

    -2.96

  • AGM Date

    25-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    388.33

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    36.98

  • BV (₹)

    -6.90

  • Sales( ₹ in Cr.)

    109.30

  • NP (in Cr.)

    -10.03

  • NP Var(%)

    -185.0

  • Div%

    0.0

  • CPS (₹)

    -1.70

  • EPS (₹)

    -2.70

  • Traded Value (₹ in Lakhs)

    388.33

  • 52 Week High

    133.50

  • 52 Week Low

    30.40

  • Price BSE

    105.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    388.33

  • P/C Ratio

    -60.50

  • P/E Ratio

    -38.70

  • Price Vs.BV

    -2.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 39.64 30.99 60.52 52.03 13.72 20.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 39.64 30.99 60.52 52.03 13.72 20.51
Other Income 0.10 0.14 1.36 2.28 4.02 0.31
Stock Adjustments 1.53 4.63 -4.55 6.39 -0.59 1.67
Total Income 41.27 35.76 57.33 60.70 17.15 22.49
EXPENDITURE :            
Raw Materials 35.06 28.64 42.67 43.02 14.99 17.75
Power and Fuel Cost 4.15 4.16 3.04 2.79 1.00 0.89
Employee Cost 5.87 5.74 0.58 4.08 2.50 2.71
Other Manufacturing Expenses 3.28 2.43 6.31 2.88 1.32 1.38
Selling and Administration Expenses 2.48 1.75 1.88 1.79 1.17 1.43
Miscellaneous Expenses 0.04 0.87 0.82 0.01 0.01 0.06
Employee Benefit Expenses 5.87 5.74 0.58 4.08 2.50 2.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 50.89 43.59 55.31 54.57 20.99 24.22
Operating Profit -9.62 -7.83 2.02 6.12 -3.85 -1.72
Interest 1.59 1.49 0.92 1.78 1.09 0.75
Gross Profit -11.21 -9.32 1.10 4.34 -4.94 -2.47
Depreciation 2.66 2.05 1.59 1.20 1.00 1.02
Profit Before Tax -13.87 -11.37 -0.49 3.14 -5.94 -3.49
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.39 0.20 0.12 0.21 -0.15 -0.24
Reported Net Profit -3.48 -11.57 -0.61 2.93 -5.79 -3.25
Extraordinary Items 0.04 -0.72 0.43 2.04 3.99 0.00
Adjusted Net Profit -3.52 -10.85 -1.04 0.89 -9.78 -3.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -60.40 -48.83 -48.22 -51.15 -45.36 -42.11
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -63.88 -60.40 -48.83 -48.22 -51.15 -45.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.04 -8.15 -0.43 2.87 -5.67 -3.19
Earnings Per Share(Adj)-Unit Curr -1.04 -8.15 -0.43 - - -
Book Value -6.18 -32.53 -24.38 -37.27 -40.14 -34.47
Book Value(Adj)-Unit Curr -6.18 -32.53 -24.38 - - -

Shareholding Pattern

  • Promoter Group

    57.92%

  • Public Share Holding

    42.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 20,477,458 55.37 20,477,458 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 942,700 2.55 942,700 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,420,158 57.92 21,420,158 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 9,700 0.03 0 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,700 0.03 0 3
2] Non Institution
Bodies Corporate 95,908 0.26 78,208 70
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,702,399 4.60 1,700,399 19
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 198,637 0.54 198,637 49
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,846,834 29.33 10,846,834 46
Individuals holding nominal share capital up to Rs. 1 lakh 2,706,463 7.32 1,437,033 9,899
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,553,642 42.06 14,264,512 10,086
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 36,983,500 100.00 35,684,670 10,094

Company Background

Oxygenta Pharmaceutical LtdPharmaceuticals - Indian - Bulk Drugs

  • Oxygenta Pharmaceutical Ltd
  • BSE Code : 19443.0
  • ISIN : INE102E01018

  • Incorporation Year

    1990

  • Registered Office

    Survey No 252/1 Aroor Village
    Sadasivapet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-08455-250080/250280

  • FAX

    91-08455-250090

  • Chairman

    Sai Sudhakar Vankineni

  • Managing Director

    Sai Sudhakar Vankineni

  • Company Secretary

    Dolly Mandhan

  • Auditor

    A M Reddy & D R Reddy

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Oxygenta Pharmaceutical Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Oxygenta Pharma 105.00 39.68 39.64 -37.77 0.00
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10